Jackson KW - Search Results

1

Enhancement of fibrinolysis by inhibiting enzymatic cleavage of precursor α2-antiplasmin.

Lee KN, Jackson KW, Christiansen VJ, Dolence EK, McKee PA. Lee KN, et al. Among authors: jackson kw. J Thromb Haemost. 2011 May;9(5):987-96. doi: 10.1111/j.1538-7836.2011.04195.x. J Thromb Haemost. 2011. PMID: 21251197 Free PMC article.

2

Hybrid peptide containing RGDF (Arg-Gly-Asp-Phe) coupled with the carboxy terminal part of alpha 2-antiplasmin capable of inhibiting platelet aggregation and promoting fibrinolysis.

Udvardy M, Schwartzott D, Jackson K, McKee PA. Udvardy M, et al. Blood Coagul Fibrinolysis. 1995 Feb;6(1):11-6. doi: 10.1097/00001721-199502000-00002. Blood Coagul Fibrinolysis. 1995. PMID: 7795148

3

[A new thrombocyte aggregation-inhibiting and fibrinolysis-promoting synthetic molecule: RGDF (Arg-Gly-Asp-Phe) coupled with the carboxyterminal antiplasmin peptide].

Udrardy M, Schwartzott D, Jackson K, McKee PA. Udrardy M, et al. Orv Hetil. 1995 Jan 15;136(3):129-33. Orv Hetil. 1995. PMID: 7870410 Review. Hungarian.

4

RGDFAP: platelet aggregation inhibitory and profibrinolytic hybrid peptide (RGDF coupled with the carboxy terminal part of alpha 2-antiplasmin) enhances plasminogen binding to platelets.

Udvardy M, Schwartzott D, Jackson K, Posan E, Rak K, McKee PA. Udvardy M, et al. Blood Coagul Fibrinolysis. 1995 Jul;6(5):481-5. Blood Coagul Fibrinolysis. 1995. PMID: 8589217

5

Purification of human alpha 2-antiplasmin with chicken IgY specific to its carboxy-terminal peptide.

Lee SC, Lee KN, Schwartzott DG, Jackson KW, Tae WC, McKee PA. Lee SC, et al. Among authors: jackson kw. Prep Biochem Biotechnol. 1997 Nov;27(4):227-37. doi: 10.1080/10826069708001281. Prep Biochem Biotechnol. 1997. PMID: 9413556

6

Effect of phenylglyoxal-modified alpha2-antiplasmin on urokinase-induced fibrinolysis.

Lee KN, Lee SC, Jackson KW, Tae WC, Schwartzott DG, McKee PA. Lee KN, et al. Among authors: jackson kw. Thromb Haemost. 1998 Oct;80(4):637-44. Thromb Haemost. 1998. PMID: 9798984

7

Characterization of wild-type and mutant alpha2-antiplasmins: fibrinolysis enhancement by reactive site mutant.

Lee KN, Tae WC, Jackson KW, Kwon SH, McKee PA. Lee KN, et al. Among authors: jackson kw. Blood. 1999 Jul 1;94(1):164-71. Blood. 1999. PMID: 10381509 Free article.

8

Cross-linking of wild-type and mutant alpha 2-antiplasmins to fibrin by activated factor XIII and by a tissue transglutaminase.

Lee KN, Lee CS, Tae WC, Jackson KW, Christiansen VJ, McKee PA. Lee KN, et al. Among authors: jackson kw. J Biol Chem. 2000 Dec 1;275(48):37382-9. doi: 10.1074/jbc.M003375200. J Biol Chem. 2000. PMID: 10958788 Free article.

9

Crosslinking of alpha 2-antiplasmin to fibrin.

Lee KN, Lee CS, Tae WC, Jackson KW, Christiansen VJ, McKee PA. Lee KN, et al. Among authors: jackson kw. Ann N Y Acad Sci. 2001;936:335-9. doi: 10.1111/j.1749-6632.2001.tb03520.x. Ann N Y Acad Sci. 2001. PMID: 11460490 Review.

10

Effect of a synthetic carboxy-terminal peptide of alpha(2)-antiplasmin on urokinase-induced fibrinolysis.

Lee KN, Jackson KW, McKee PA. Lee KN, et al. Among authors: jackson kw. Thromb Res. 2002 Feb 1;105(3):263-70. doi: 10.1016/s0049-3848(02)00030-0. Thromb Res. 2002. PMID: 11927133

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

91 results

Search Page

Filters